Fresenius Medical Care stock: Berenberg cuts target to EUR 37
Published on 11/21/2026 at 12:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBerenberg cuts target, keeps Neutral
- Berenberg analyst Harry Gillis reduced the price target for Fresenius Medical Care on November 18.
- The bank maintained its Neutral recommendation as the latest analyst view for the dialysis company.
Fresenius Medical Care stock last traded at 37.36 euros on Lang & Schwarz at 12:03 CET on Saturday, November 21, 2026.
Berenberg lowers its price target
On Wednesday, November 18, Berenberg analyst Harry Gillis reduced the price target for Fresenius Medical Care from 42 euros to 37 euros while maintaining a Neutral recommendation, according to MarketScreener.
The revised target leaves Berenberg's assessment unchanged on the rating scale but signals a more cautious valuation view. For investors, the unchanged Neutral stance and lower target provide the central analyst message for the week.
What the analyst view means
Fresenius Medical Care operates dialysis clinics and supplies products for kidney-care treatment. The target change is an analyst estimate rather than a company forecast or a change in the group's operating guidance.
The Saturday Lang & Schwarz quote gives investors the latest available trading indication before the new week. The next regular market sessions will show how the share develops after the analyst revision and alongside broader healthcare-market moves.
Fresenius Medical Care stock at a glance
- Company: Fresenius Medical Care AG & Co. KGaA
- ISIN: DE0005785802
- Analyst: Berenberg, Harry Gillis
- Recommendation: Neutral, maintained on November 18, 2026
- Price target: 37 euros, reduced from 42 euros on November 18, 2026
- Latest quote: 37.36 euros on Lang & Schwarz at 12:03 CET on November 21, 2026
Healthcare shares remain part of the wider market setting. Current market reports provide the broader trading context.
